Clinical Trials · NCT05857085
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- General and Teaching Hospital Celje
- Enrollment
- 90
- Start date
- Dec 2021
- Locations
- 1 site, Slovenia
- Primary endpoint
- evaluation of endothelial function by flow mediated dilation (FMD) of brachial artery